At a glance
- Originator Aventis
- Class Antipsychotics
- Mechanism of Action Dopamine D2 receptor antagonists; Serotonin 5-HT2 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Psychotic disorders
Most Recent Events
- 06 Oct 1998 No-Development-Reported for Psychotic disorders in USA (Unknown route)
- 17 Apr 1996 Preclinical development for Psychotic disorders in USA (Unknown route)